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Abstract 
Glycolysis is an essential component of cellular metabolism associated with pluripotent stem 
cells (PSCs). Two new papers, Gu et al. in Cell Stem Cell and Zhang et al. in Cell Reports, 
demonstrate that glycolytic flux is dynamically increased in human primed PSCs upon feeder-
free cultivation or conversion into naïve state. 
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Main text  
Pluripotent stem cells (PSCs) preferentially rely on glycolytic metabolism, despite the 
relatively limited efficiency in energy output compared to oxidative metabolism (reviewed in 
(Ryall et al., 2015)). Several explanations for this counterintuitive regulation have been put 
forth, including the need to increase the biosynthetic pathways through the pentose phosphate 
pathway (PPP) to accommodate biomass requirements in rapidly cycling cells and the 
necessity to prevent genomic damage caused by free radicals generated as by-products of 
mitochondrial oxidative phosphorylation (OXPHOS). Moreover, glycolysis-derived 
metabolites may represent important modulators of stem cell epigenetics (Ryall et al., 2015). 
Consequently, a dramatic glycolytic shift occurs during cell fate conversion (from somatic 
cells to PSCs or from PSCs to differentiated progenies (Prigione et al., 2010). Two new 
papers in Cell Stem Cell and Cell Reports (Gu et al., 2016; Zhang et al., 2016) employ 
metabolic flux analysis to demonstrate that PSCs, even while maintaining pluripotency, 
dynamically modulate their glycolytic metabolism in response to changes in the culture 
conditions or conversion between different PSC states.  
Gu et al. (2016) investigated the metabolic changes occurring during the transition 
between human naïve and primed pluripotent states. These two PSC states respectively 
represent pre-implantation cells in the inner cell mass and post-implantation cells in the 
epiblast (Takashima et al., 2014; Theunissen et al., 2014). Previous studies demonstrated that 
human and mouse naïve PSCs contain mitochondria with more immature morphology than 
primed PSCs (Zhou et al., 2012). At the same time, human and mouse naïve PSCs exhibit 
increased OXPHOS (Takashima et al., 2014; Zhou et al., 2012). Now Gu et al. (2016) 
demonstrate that human naïve PSCs, both newly derived and those cultured in previously 
reported reversion conditions (Takashima et al., 2014; Theunissen et al., 2014), in addition to 
higher mitochondrial oxygen consumption also display elevated glycolytic rates. Human 
naïve PSCs consumed more glucose, produced more lactate, and incorporated more glucose 
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carbons into lactate and into purine and pyrimidine nucleotides, implying increased flux 
towards glycolysis and the PPP. This is in contrast with the reduction of glycolytic 
metabolism previously found in mouse naïve PSCs (Zhou et al., 2012). Gu et al. (2016) 
suggest that this discrepancy may be due to species-related differences. In particular, they 
observed that nuclear C-MYC, which promotes glucose metabolism, is higher in primed PSCs 
in mice, while it is higher in naïve PSCs in humans. Accordingly, using RNA-Seq analysis, 
Gu et al. (2016) identified significant enrichment of MYC-regulated gene sets in human naïve 
versus primed PSCs.  
The concomitant raise of OXPHOS and glycolysis observed by Gu et al. (2016) might 
be a consequence of the bivalent metabolic state of naïve PSCs, which can switch to one or 
the other metabolic route according to the demand (Zhou et al., 2012). In fact, it has been 
suggested that glycolysis may represent the basal energy source for naïve PSCs and 
mitochondrial respiration their spare capacity (Carbognin et al., 2016). Accordingly, 
inhibition of glycolysis is not as detrimental for naïve PSCs as it is for primed PSCs 
(Takashima et al., 2014). It would be interesting to compare the effects of OXPHOS 
inhibition. Perhaps, naïve and primed PSCs would equally survive as they both rely on 
glycolysis. Overall, naïve PSCs appear equipped with a metabolic program that enables 
efficient adaption to different environmental conditions, including those not favorable for 
glycolysis, which might also partially explain their enhanced clonogenic properties.  
Signaling molecules and culture conditions play a contributing role in the primed to 
naïve conversion. LIF is employed in the majority of naïve media (Gu et al., 2016; Takashima 
et al., 2014) and activates mitochondrial respiration (Carbognin et al., 2016). Activin is 
included in some naïve media (Gu et al., 2016; Theunissen et al., 2014) and may stimulate 
glycolysis through the stabilization of Hypoxia-Inducible Factor-1 alpha (HIF1a) (Zhou et al., 
2012). HIF1a is a master metabolic regulator contributing to the glycolytic shift associated 
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with the induction of pluripotency (Prigione et al., 2014). Its role in the metabolism of human 
naïve PSCs warrants further investigation. 
Zhang et al. (2016) further explored the impact of culture conditions on pluripotency 
through a comprehensive metabolic assessment of human primed PSCs grown as feeder-free 
(FF) or as feeder-supported (FS) cultures. Elevated glucose flux towards glycolysis and the 
PPP was detected in FF versus FS PSCs. Similarly, Gu et al. (2016) observed increased 
glucose metabolism and glucose incorporation into biosynthetic pathways in FF PSCs. In 
addition, Gu et al. (2016) found that FF PSCs were more sensitive to the inhibition of MCT1, 
a target of MYC-driven glycolysis. This proliferation defect was rescued by the addition of 
feeder-conditioned media. The findings of Zhang et al. (2016) may provide a plausible 
explanation for this effect, since a lack of lipid supplementation was identified within the 
media commonly employed for FF cultivation. Zhang et al. (2016) demonstrate that FF PSCs 
increase glutamine consumption and glutamine-mediated reductive carboxylation. This latter 
pathway can be active upon HIF1a stabilization and is important for lipid biosynthesis. De 
novo lipogenesis was indeed increased in FF cultures. Remarkably, lipid supplementation was 
sufficient to convert key metabolic features of FF PSCs back to a state similar to that of FS 
PSCs. Therefore, nutrients contained within PSC media may dramatically influence PSC 
metabolism. In light of these findings, we speculate that lipid supplementation of naïve PSCs 
might potentially enable their FF cultivation. 
Importantly, Zhang et al. (2016) showed that mitochondrial flux is also active in 
primed FS PSCs and significantly increased in FF PSCs upon lipid supplementation. Hence, 
the maintenance of human primed pluripotency might also depend on mitochondrial 
metabolism. In accordance, elevated alpha-ketoglutarate (αKG), which promotes 
histone/DNA demethylation and blocks the mitochondrial ATP synthase, can support mouse 
naïve PSCs but significantly accelerates the differentiation of human primed PSCs (TeSlaa et 
al., 2016).  
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Altogether, glycolysis remains a defining feature of pluripotency. Nevertheless, PSCs 
can dynamically modulate their metabolism in response to media composition, oxygen 
tension, and signaling molecules (Figure 1). Since each cell fate is characterized by a defined 
transcriptional signature, we may expect the same for metabolic traits. The dynamic nature of 
metabolism indicates that assigning a unique bona fide metabolic signature to cell fates might 
turn out to be very challenging. 
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Figure legend. Metabolic control of pluripotent cell fates. The energy metabolism of 
pluripotent stem cells (PSCs) is modulated by environmental cues, including nutrients within 
the media, oxygen tension, and signaling molecules. Metabolism can in turn influence cellular 
epigenetics through metabolites derived from glycolysis and the tricarboxylic acid (TCA) 
cycle or exogenously provided. This metabolic-epigenetic crosstalk contributes to define the 
cellular identity. As a result, the fate of PSCs can be the maintenance or the loss of 
pluripotency. PPP: pentose phosphate pathway; FF: feeder-free; FS: feeder-supported; αKG: 
alpha-ketoglutarate. 
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